Psychotropic prescriptions in a sample including both healthy and mood and disruptive disordered preschoolers: relationships to diagnosis, impairment, prescriber type, and assessment methods.

Full Abstract

OBJECTIVE:
Epidemiological data has shown that psychotropic medications are being prescribed to preschoolers at increasing rates. The diagnostic context and functional impairment of these preschoolers remains unknown. This investigation aimed to address these questions in a sample of preschoolers who were either without symptoms (healthy) or with mood and disruptive disorders by assessing them using a structured diagnostic interview and measure of impairment.

METHOD:
Preschoolers aged 3.0 to 5.11 without symptoms and those with symptoms of mood and disruptive disorders were recruited from primary care and daycare sites in the St. Louis area to participate in a psychiatric evaluation that included information about psychotropic prescriptions from community practitioners.

RESULTS:
Seven percent of preschoolers (n = 19) out of a total sample of n = 267 were prescribed psychotropic medications. Fifty-two percent of preschoolers in the total sample met criteria for an Axis I psychiatric disorder. Presence of an Axis I disorder was significantly related to psychotropic prescription (p < 0.01). Among preschoolers who met criteria for an Axis I disorder 12% received psychotropics (Dx/Rx group). The Dx/Rx group was more impaired than those with a diagnosis who were not prescribed psychotropics (p < 0.001). Among preschoolers taking psychotropic medications, two failed to meet criteria for any Axis I disorder.

CONCLUSION:
In this sample, most psychotropic medications were prescribed for impaired preschoolers with an Axis I diagnosis. These findings shed some light on the prescribing trends among mood and disruptive disordered preschoolers.

Learn Faster Today Improve your study skills

Author information

Author/s: Luby, Joan L (JL); Stalets, Melissa Meade (MM); Belden, Andy C (AC);

Affiliation: Washington University School of Medicine, Department of Psychiatry, St. Louis, Missouri 63108, USA. lubyj(-atsign-)msnotes.wustl.edu

Grants: R01 064769 (Agency:PHS HHS)

Journal and publication information

Publication Type: Journal Article; Research Support, N.I.H., Extramural

Journal: Journal of child and adolescent psychopharmacology (J Child Adolesc Psychopharmacol), published in United States. (Language: eng)

Reference: 2007-Apr; vol 17 (issue 2) : pp 205-15

Dates: Created 2007/05/10; Completed 2007/06/28; Revised 2008/11/21;

PMID: 17489715, status: MEDLINE (last retrieval date: 12/26/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Attention Deficit and Disruptive Behavior Disorders - drug therapy
Case-Control Studies
Child, Preschool
Community Medicine
Drug Prescriptions - statistics & numerical data
Drug Utilization

Humans
Mood Disorders - drug therapy
Primary Health Care
Psychotherapy - statistics & numerical data
Psychotropic Drugs - administration & dosage
Severity of Illness Index

Associated Chemicals: Psychotropic Drugs (0)

These are the highest related articles currently in the database:

See 100+ related articles.